New oral anticoagulants in cardiovascular and cerebrovascular diseasesLI Shu-ya, DU Wan-liang, WANG Yong-jun1191-1194,1209
Biotechnology industry development: international experience and China selectionZHANG Li, ZHU Zhen-jia1195-1199,1219
Strategies for quality control of enoxaparin sodiumZHANG Xiao-hong, REN Lian-jie, YU Li, HUANG Xiao-long, ZHAO Hui-ling1200-1202
Analysis of significant under-usage of warfarin in patients with nonvalvular atrial fibrillationWANG Chun-juan, WANG Chun-xue, WANG Yong-jun, WANG Yi-long, ZHAO Xing-quan, LIU Li-ping, David Z.Wang, LI Hao, YANG Zhong-hua1203-1209
Protective effect of auraptene on cerebral ischemia-induced vascular dementia in ratsCHEN Hai-fang, LUO Li-ping, YUAN Jin-bin, LUO Xiao-quan, LI Zheng-hong, YANG Biao, YANG Wu-liang1210-1213
Comparison of the new oral anticoagulant drug with warfarin to prevent stroke in patients with atrial fibrillationFANG Kun, CHENG Xin, DONG Qiang1214-1219
Research progress of the new anticoagulant drug rivaroxaban in the prevention of cerebral embolism in patients with atrial fibrillationWANG Feng-zhi, HE Zhi-yi1224-1226
Dabigatran etexilate, a novel oral anticoagulant for stroke prevention in patients with atrial fibrillationZHANG Yin-xi, DING Mei-ping1227-1231,1236